The National Cancer Institute grant, award to Principal Investigator Gary R. Morrow, funds a leadership role in a nationwide clinical research network to investigate cancer-related side effects.
A new report examines the host of potential health-related issues that communities in areas of the country suitable for natural gas extraction may face and provides direction for future research.
Biologists Vera Gorbunova and Andei Seluanov have discovered one reason for the the increase in DNA damage as we age: the primary repair process begins to fail and is replaced by one that is less accurate.
Anton Zeilinger, one of the world’s leading experts in the field of quantum optics, will present a free, public lecture Tuesday at the University of Rochester. The talk is designed to convey the exciting frontiers of quantum mechanics to a general audience.
For the first time, the middle-steps in the process that creates the protein-making machinery of bacterial cells—called the ribosomes—has been isolated. A new study by biologist Gloria Culver suggests that blocking these pathways may help kill off drug-resistant bacteria.
An international team of researchers– co-lead by researchers in the School of Medicine and Dentistry – has identified a new inherited neuromuscular disorder. The new disease was diagnosed in two families, one in the U.S. and the other in Great Britain.
A new combination of materials can efficiently guide electricity and light along the same tiny wire, a finding that could be a step towards building computer chips capable of transporting digital information at the speed of light.
Now, with the assistance of a web camera and software algorithms, the face can also reveal whether or not an individual is experiencing atrial fibrillation. The technology was developed in a partnership between the University of Rochester School of Medicine and Dentistry and Xerox.
University researchers have introduced a new method, called compressive direct measurement, that allowed the team to reconstruct a quantum state at 90 percent fidelity using only a quarter of the measurements required by previous methods.
Each of the experimental HIV drugs has been in development for several years, one at Rochester and the other at Nebraska. Earlier this year they were tested together, to determine whether one drug might interfere with the other. To the astonishment of the researchers, the opposite occurred: one drug boosted the effectiveness of the other.